Published By
Created On
10 May 2022 16:13:14 UTC
Transaction ID
Cost
Safe for Work
Free
Yes
News Roundup | Pfizer’s mRNA-based COVID-19 Vaccine Durability Problems Continue with Fourth Dose
Join The Conversation! | https://trialsitenews.com/
Israeli researchers tracking COVID-19 vaccination investigated the benefits of a fourth dose of BNT162b2, Pfizer-BioNTech's mRNA vaccine in an effort to reduce the strains on the Israeli healthcare system brought by the Omicron (B.1.1.529) strain of COVID-19. The fourth booster dose was authored for persons aged 60 and above as well as high-risk populations and healthcare workers if over four months had passed since receiving a third (booster) dose. Tapping into the national database from the Israeli Ministry of Health, the team represented by corresponding author Dr. Yair Goldberg with Technion—Israel Institute of Technology sought to better understand the effectiveness of the fourth booster dose as compared to only three doses against confirmed infection as well as severe illness in a targeted study population of Israel-based elderly individuals. They found, unfortunately, that the durability of the BNT162b2 product remains a problem, given vaccine effectiveness wanes rapidly starting at week 5 after administration. While the protection against severe disease held, the study team only evaluated the product for six weeks which is, frankly, a serious limitation. The authors acknowledge a “modest” benefit to a fourth dose while not delving into other considerations such as safety.
...
https://www.youtube.com/watch?v=1BvMWYc-Qh4
Israeli researchers tracking COVID-19 vaccination investigated the benefits of a fourth dose of BNT162b2, Pfizer-BioNTech's mRNA vaccine in an effort to reduce the strains on the Israeli healthcare system brought by the Omicron (B.1.1.529) strain of COVID-19. The fourth booster dose was authored for persons aged 60 and above as well as high-risk populations and healthcare workers if over four months had passed since receiving a third (booster) dose. Tapping into the national database from the Israeli Ministry of Health, the team represented by corresponding author Dr. Yair Goldberg with Technion—Israel Institute of Technology sought to better understand the effectiveness of the fourth booster dose as compared to only three doses against confirmed infection as well as severe illness in a targeted study population of Israel-based elderly individuals. They found, unfortunately, that the durability of the BNT162b2 product remains a problem, given vaccine effectiveness wanes rapidly starting at week 5 after administration. While the protection against severe disease held, the study team only evaluated the product for six weeks which is, frankly, a serious limitation. The authors acknowledge a “modest” benefit to a fourth dose while not delving into other considerations such as safety.
...
https://www.youtube.com/watch?v=1BvMWYc-Qh4
Author
Content Type
Unspecified
video/mp4
Language
English
More from the publisher
Controlling
VIDEO
DOZEN
dozens-of-french-farmers-arrested-as
The ongoing French Farmer protest has escalated, with tensions particularly high in Paris. On January 31st, French police detained over 79 individuals who broke into a wholesale food market south of Paris. This incident is part of a larger movement where convoys of tractors and protesting farmers have closed in on Paris, Lyon, and other strategic locations across France. The protests are driven by farmers' demands for higher incomes, less bureaucracy, and protection against cheap imports. They are also protesting against the government's plans to reduce subsidies on agricultural diesel and the requirement to convert 4% of farmland to "non-productive" areas for environmental purposes. The French government has offered some concessions, but these have been deemed insufficient by the farmers.
...
https://www.youtube.com/watch?v=o4jvtVpDqdQ
Transaction
Created
4 months ago
Content Type
Language
video/mp4
English
Controlling
VIDEO
SOUTH
south-african-groups-sue-govt-to-stop
Join The Conversation! | https://trialsitenews.com/
Although the formal drug and vaccine regulator called South Africa Health Products Regulatory Authority (SAHPRA) deems the COVID-19 vaccines safe and effective, as does the medical establishment (licensing bodies, medical schools, associations), and most of societies’ governing apparatus at least three community groups claim a very different contrarian reality. The three non-profit organizations disagree so much that they have taken their fight to the Gauteng High Court, Pretoria, to stop the COVID-19 mass vaccination program.
...
https://www.youtube.com/watch?v=cS6teoc9pgE
Transaction
Created
4 months ago
Content Type
Language
video/mp4
English
Controlling
VIDEO
CLINI
clinical-trials-and-research-news-20
Join us as we go over our top stories from the week:
Ex-#NFL Player Turned Investigator to Lead Expanded Access Study With #FDA Approval of Paradigm #Biopharmaceuticals IND.
Advanced Gene Therapy TR002 Moves to Phase III Clinical Trial for #Mesothelioma.
FirstHealth Makes History Enrolling the First Patient in Immunotherapy Clinical Trial Addressing #CervicalCancer.
San Francisco-Based, #InfectiousDisease-Focused Vir Biotechnology Now Files for IPO.
Large Payer Cigna to Fully Cover Multi-Million Dollar #GeneTherapies.
California’s Central Valley Center of German-Originated $28M Biotechnology Firm Investment.
UCLA Investigator Leads Small Clinical Trial that Actually Reverses #Aging Process by 2.5 Years on Average.
Thomas Jefferson University-based Research: Clinical Trials Under Siege in America.
#Genentech Reports Results From Phase 3 BLOCKSTONE Trial; #Xofluza Reduces #Flu Threat by 86% Following Exposure.
Center for Psychedelic Research Opens at #JohnsHopkins Medicine.
Northwestern Medicine’s ‘Successful’ #Immunotherapy and #AutoimmuneDisease #Research Program to Shut its’ Doors.
Drug Makers Responding to Price Pressures and Start Dropping #Insulin #Costs.
Penn PACE: Medicine & Radiology Receive $8.9M & Build a Center of Excellence Dedicated to #Opioid Use #Disorder Research.
#Rheumatology Network Interviews Clinical #Investigator for the SELECT-COMPARE Trial for Rinovoq.
@Microsoft and #AstraZeneca Team up for AI Incubator.
Tel Aviv’s #IchilovHospital CEO Ronnie Gamzu: Accelerate the Digital and #AI Initiatives.
@KaiserPermanente Study Reveals At-Home #Dialysis Improves #PatientQuality of Life.
@MountSinai Launches the Lipschultz Center for Cognitive #Neuroscience.
Time Stamps:
00:35 – Cancer
02:30 – Clinical Trials
07:07 – Flu
07:51 – PTSD
08:48 – SiteWatch Challenge
12:35 – Opioid Use News
13:13 – Arthritis
15:43 – Artificial Intelligence
18:22 – Kidney
19:43 - Neuroscience
Article Links:
https://www.trialsitenews.com/drug-makers-responding-to-price-pressures-and-start-dropping-insulin-costs/
https://www.trialsitenews.com/rheumatology-network-interviews-clinical-investigator-for-the-select-compare-trial-for-rinovoq/
Make sure to tune in on Sep 18th for our podcast, where we will be talking to Sharee Page, about your battle with breast cancer. You find her on YouTube as Breast Cancer Babe.
...
https://www.youtube.com/watch?v=fHagwel5pk4
Transaction
Created
4 months ago
Content Type
Language
video/mp4
English
Controlling
VIDEO
CLINI
clinical-trials-and-research-news-13
Join us as we go over our top stories from the week:
#Merck and Pfizer Discuss Site Selection
The Wire Goes Bio: #Baltimore’s Becoming a Biotech Powerhouse
Richmond University Medical Center Office of Clinical Research Names Director
LMC Manna Expands Research as a Care Option Deeper into the Ontario #Canada Community
#Kaiser Permanente’s Washington Health Research Institute Onboards New Leader
HCA Healthcare: America’s Largest Health System & Clinical Trials
#Robocath Successfully Carries Out Its First Robotic Coronary Angioplasties in Humans
Baby Pia Denied Compassionate Use: Something ‘Ain’t’ Right in Basel
#Bayer Invests More into Boston: $30+M Joint Lab with Partners Healthcare Founders
Chinese Foundation & #GlaxoSmithKline Team Invest to Support Lupus Patients in #China
Bavarian Nordic Receives FDA Approval for Jynneos #Vaccine Against #Smallpox and #Monkeypox Disease
Researchers at #Stanford Discover Common Denominator In Several #Neurodegenerative Diseases
Morristown Medical Center Represents the Future of Clinical Research as a Care Option: And it’s Now
AstraZeneca’s FLAURA Study Reveals Lung Cancer Survival Improvements with Osimertinib
Time Stamps:
Clinical Trial 00:31
Robotics 05:09
SiteWatch 05:51
Lung Disease 06:33
Smallpox 07:28
Neurodegenerative 08:03
Cancer 08:48
...
https://www.youtube.com/watch?v=vAEdyKTMuTY
Transaction
Created
4 months ago
Content Type
Language
video/mp4
English
Controlling
VIDEO
LEAKE
leaked-ema-emails-reveal-concern-with
Join The Conversation! | https://trialsitenews.com/
Trial Site News recently were able to review leaked internal emails from the European Medicines Agency (EMA) and meeting report between the agency and Pfizer. The EMA oversees the evaluation and supervision of medicinal products for the European Union. Like other regulatory health bodies, its main responsibility is to protect and promote public health. Snapshots of internal EMA email correspondence; a November 26, 2020, PowerPoint presentation from a pivotal meeting between Pfizer and the agency, as well as a confidential 43-page Pfizer report were provided by an anonymous source because of their trust in Trial Site’s commitment to transparency, accessibility, and accountability in furtherance of a highly ethical, quality-focused and public health-centric biomedical research industry.
Article Link | https://www.trialsitenews.com/a/what-the-leaked-ema-emails-docs-reveal-major-concerns-with-pfizer-c-19-vaccine-batch-integrity-and-the-race-to-authorise-cdda0ba2
...
https://www.youtube.com/watch?v=i5TUTDABtgk
Transaction
Created
4 months ago
Content Type
Language
video/mp4
English
Controlling
VIDEO
THE S
the-scoop-on-monkeypox-with-infectious
Join The Conversation! | https://trialsitenews.com/
Dr. Klausner is a world renowned infectious disease and public health expert currently with Keck School of Medicine at the University of Southern California. He is also a professor of population and public health sciences and his research interests include applied epidemiology and the prevention and control of infectious diseases of public health importance, including HIV, STDs, TB and COVID-19.
...
https://www.youtube.com/watch?v=vQutWSOeBRQ
Transaction
Created
4 months ago
Content Type
Language
video/mp4
English
Controlling
VIDEO
CLINI
clinical-trials-and-research-news-39
Australian Research Team Identifies #Ivermectin Zaps #COVID-19 in Cell Cultures.
#Amgen now Jumps into #COVID-19 Development Race by Inking a Partnership with #AdaptiveBiotechnologies.
#NIH Intensifies #COVID-19 Testing with Major 10,000 Volunteer Testing Now Enrolling.
Multicenter Preclinical (animal) Research Reports Combining #Hydroxychloroquine or #Chloroquine with #Metformin Toxic to Mice: People Beware.
#Mesoblast Receives Clearance for Use of Stem Cell Therapy Product in Patients with #COVID-19 #ARDS.
#Scripps Research Discovers New #COVID-19 Antibody Known as #CR3022.
...
https://www.youtube.com/watch?v=CtXGPD1mrkM
Transaction
Created
4 months ago
Content Type
Language
video/mp4
English
Controlling
VIDEO
DR. A
dr.-ariel-israel-discusses-the-covid-19
Join The Conversation! | https://trialsitenews.com/
Dr. Ariel Israel MD, PhD, Head of Leumit Research Institute, discusses the COVID-19 situation in Israel & his research on the vaccine.
Dr. Ariel Israel Study links:
https://www.medrxiv.org/content/10.1101/2021.08.03.21261496v1.full
https://www.medrxiv.org/content/10.1101/2021.08.19.21262111v1
https://elifesciences.org/articles/68165
https://www.medrxiv.org/content/10.1101/2020.09.04.20188268v1
https://elifesciences.org/articles/68165.pdf
...
https://www.youtube.com/watch?v=Vw5SS3REu4A
Transaction
Created
4 months ago
Content Type
Language
video/mp4
English
Controlling
VIDEO
NIH S
nih-study-neuropathic-symptoms-with-sars
Join The Conversation! | https://trialsitenews.com/
A team of researchers from various institutes within the National Institutes of Health (NIH) led by corresponding author Avindra Nath, a senior investigator and clinical director at the National Institute of Neurological Disorders and Stroke (NINDS), part of the NIH, have reported on study results associating the COVID-19 vaccines with neuropathic side effects.
This observational and yet to be reviewed study should not be cited as evidence until it is formally peer reviewed. Moreover, the authors declare that more time is necessary for scientists and physicians to determine the true nature of any causal relation between the COVID-19 vaccines and neuropathies. The results are posted in medRxiv.
Study Link | https://www.medrxiv.org/content/10.1101/2022.05.16.22274439v1
...
https://www.youtube.com/watch?v=r_zpMFaMuhs
Transaction
Created
4 months ago
Content Type
Language
video/mp4
English